2.85 (-%)
As of Dec 02, 2024
Source:
Sana Biotechnology, Inc is developing cell engineering programs to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system disorders, among others.
Country | United States |
Headquarters | seattle, washington |
Phone Number | (206) 701-7914 |
Industry | manufacturing |
CEO | Steven D. Harr, M.D. |
Website | www.sana.com |